Kamphorst et al. demonstrated an increase of PD1+CD8+ cells in PBLs in patients diagnosed with advanced lung cancer and showed clinical benefit following PD-1-targeted therapy [25]. The gene discussed is CD8A; the disease is lung carcinoma.